Delisting risk
LAB · NASDAQ · Medical - Specialties

Standard BioTools

Sells retained mass-cytometry and microfluidic genomics systems after the SomaScan sale.

$0.6548
After-hours close+0.02 (+2.47%)
At close$0.6390(−2.14%)
DateEstimateReportedSurprise
Nov 2026−$0.02
Aug 2026−$0.01−$0.07−449.0%
May 2026−$0.02−$0.020.0%
Feb 2026−$0.03$0.06+300.0%
Nov 2025−$0.03−$0.04−60.0%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Feb 2025
Oct 2024
Jul 2024
May 2024
Feb 2024
Nov 2023
Aug 2023
May 2023
Feb 2023
Nov 2022
Aug 2022
May 2022
Feb 2022
Nov 2021
Aug 2021
May 2021
Feb 2021
Nov 2020
Aug 2020
May 2020
Feb 2020
Nov 2019
Aug 2019
May 2019
Feb 2019
Nov 2018
Aug 2018
May 2018
Feb 2018
Nov 2017
Aug 2017
May 2017
Feb 2017
Nov 2016
Aug 2016
May 2016
Feb 2016
Oct 2015
Aug 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 3, 2026−$0.02$18.8M
Aug 5, 2026−$0.01−$0.07−449.0%$20.8M$20.1M−3.4%
May 5, 2026−$0.02−$0.020.0%$17.8M$21.1M+18.8%
Feb 24, 2026−$0.03$0.06+300.0%$18.5M$23.8M+28.6%
Nov 4, 2025−$0.03−$0.04−60.0%$18.5M$19.6M+5.7%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 11, 2025
May 6, 2025
Feb 26, 2025
Oct 30, 2024
Jul 31, 2024
May 8, 2024
Feb 28, 2024
Nov 7, 2023
Aug 8, 2023
May 9, 2023
Feb 14, 2023
Nov 8, 2022
Aug 8, 2022
May 5, 2022
Feb 17, 2022
Nov 8, 2021
Aug 5, 2021
May 6, 2021
Feb 10, 2021
Nov 5, 2020
Aug 6, 2020
May 7, 2020
Feb 10, 2020
Nov 5, 2019
Aug 1, 2019
May 2, 2019
Feb 7, 2019
Nov 1, 2018
Aug 2, 2018
May 3, 2018
Feb 8, 2018
Nov 2, 2017
Aug 3, 2017
May 4, 2017
Feb 8, 2017
Nov 3, 2016
Aug 4, 2016
May 5, 2016
Feb 4, 2016
Oct 29, 2015
Aug 6, 2015